mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
BRD-K27188169 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.8 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.0093 |
0.8 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.8 |